Hannah Valantine, Director, on July 16, 2026, sold 28,779 shares in Caredx (CDNA) for $1,040,243. Following the Form 4 filing with the SEC, Valantine has control over a total of 36,686 common shares of the company, with 36,686 shares held directly.
SEC Filing: